12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaNov 6 07:05 ET

Processa Pharma Q3 2024 GAAP EPS $(1.03) Misses $(1.00) Estimate

BenzingaOct 30 17:00 ET

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results

GlobeNewswireOct 30 16:15 ET

Processa Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECOct 30 16:07 ET · Announcements

Processa Pharmaceuticals Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow JonesOct 3 07:53 ET · Ratings

Processa Pharma Analyst Ratings

BenzingaOct 3 07:41 ET · Ratings